News

Stepan lands $500M credit line, lifting borrowing capacity by $50M

What's the deal? Stepan CompanyDealroom has a profile for this one. Try Dealroom → (NYSE: SCL) has entered a $500 million five-year credit agreement, replacing a prior $450 million package and giving the specialty chemicals maker more liquidity and borrowing headroom. The deal, signed September 25, 2026, was led by JPMorgan Chase Bank and Bank of America.

The details: The facility pairs a $350 million multicurrency revolving credit line with a $150 million delayed draw term loan. Both mature September 25, 2031.

It replaces a $350 million revolver and $100 million term loan set up in June 2022 — a $50 million increase in committed capacity.

Why now? The refinancing extends Stepan's debt maturities by five years and locks in fresh liquidity. Outstanding obligations under the old agreement were rolled into the new loans via a "cashless roll," the filing notes.

What's the endgame? Stepan can draw funds to cover working capital, fund permitted acquisitions and capital spending, and for general corporate purposes. An expansion option lets it request up to $250 million more, bringing potential capacity to $750 million.

Pricing follows a grid tied to net leverage: loans carry a base rate plus 0.125% to 0.625%, or an adjusted SOFR or EURIBOR rate plus 1.125% to 1.625%. Commitment and ticking fees range from 0.125% to 0.225% per annum.

The syndicate: JPMorgan Chase Bank serves as administrative agent, swingline lender, and an issuing bank; Bank of America is syndication agent and an issuing bank. CitibankDealroom has a profile for this one. Try Dealroom →, PNC Bank, and U.S. BankDealroom has a profile for this one. Try Dealroom → act as co-documentation agents. JPMorgan and BofA SecuritiesDealroom has a profile for this one. Try Dealroom → are joint lead arrangers and joint bookrunners.

The signal: At $500 million, the facility ranks in the upper reaches of post-IPO debt deals, sitting in roughly the 37th percentile by size. For an established chemicals maker, the tighter spreads on lower leverage tie borrowing costs to balance-sheet discipline — and the expansion option keeps acquisition firepower ready without a new arrangement.

Read more: minichart.com.sg

Image credit: Kitmondo.com

More top stories